SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-300141
Filing Date
2022-12-07
Accepted
2022-12-07 16:04:13
Documents
17
Period of Report
2022-12-06
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d421267d8k.htm   iXBRL 8-K 40385
2 EX-2.1 d421267dex21.htm EX-2.1 24799
3 EX-99.1 d421267dex991.htm EX-99.1 11251
8 GRAPHIC g421267g1207031315544.jpg GRAPHIC 3596
9 GRAPHIC g421267g1207031315731.jpg GRAPHIC 2834
  Complete submission text file 0001193125-22-300141.txt   274414

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pbax-20221206.xsd EX-101.SCH 4526
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbax-20221206_def.xml EX-101.DEF 14751
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbax-20221206_lab.xml EX-101.LAB 25002
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbax-20221206_pre.xml EX-101.PRE 15849
11 EXTRACTED XBRL INSTANCE DOCUMENT d421267d8k_htm.xml XML 7193
Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40877 | Film No.: 221450260
SIC: 6770 Blank Checks